CD4 and COVID-19: Patients who had a poor COVID-19 outcome were less often on cART (75% vs. 93%, p = 0.0073) and had a lower median CD4+ cell count (403 [IQR: 172–582.5] vs. 568 [IQR: 348–861], p = 0.0099).